Janney Montgomery Scott’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.1M | Buy |
50,631
+3,212
| +7% | +$703K | 0.03% | 523 |
|
2025
Q1 | $10.6M | Buy |
47,419
+2,350
| +5% | +$526K | 0.03% | 514 |
|
2024
Q4 | $14.8M | Buy |
+45,069
| New | +$14.8M | 0.04% | 427 |
|
2024
Q3 | – | Sell |
-48,248
| Closed | -$15.9M | – | 2861 |
|
2024
Q2 | $15.9M | Sell |
48,248
-1,907
| -4% | -$628K | 0.05% | 376 |
|
2024
Q1 | $19.8M | Sell |
50,155
-3,155
| -6% | -$1.25M | 0.06% | 326 |
|
2023
Q4 | $18.8M | Sell |
53,310
-1,790
| -3% | -$630K | 0.06% | 316 |
|
2023
Q3 | $20.7M | Sell |
55,100
-394
| -0.7% | -$148K | 0.08% | 246 |
|
2023
Q2 | $21.2M | Buy |
55,494
+136
| +0.2% | +$52K | 0.07% | 246 |
|
2023
Q1 | $19.2M | Buy |
55,358
+4,043
| +8% | +$1.4M | 0.08% | 242 |
|
2022
Q4 | $12.1M | Buy |
51,315
+7,701
| +18% | +$1.81M | 0.05% | 372 |
|
2022
Q3 | $10.7M | Buy |
43,614
+1,798
| +4% | +$442K | 0.05% | 364 |
|
2022
Q2 | $12.5M | Sell |
41,816
-15,195
| -27% | -$4.56M | 0.06% | 298 |
|
2022
Q1 | $23.4M | Buy |
57,011
+6,280
| +12% | +$2.58M | 0.1% | 202 |
|
2021
Q4 | $23.8M | Sell |
50,731
-4,974
| -9% | -$2.33M | 0.09% | 206 |
|
2021
Q3 | $23.6M | Buy |
55,705
+2,390
| +4% | +$1.01M | 0.1% | 193 |
|
2021
Q2 | $19.1M | Buy |
53,315
+5,492
| +11% | +$1.97M | 0.08% | 220 |
|
2021
Q1 | $13.5M | Buy |
47,823
+30,041
| +169% | +$8.47M | 0.07% | 266 |
|
2020
Q4 | $5.04M | Buy |
17,782
+1,673
| +10% | +$474K | 0.02% | 544 |
|
2020
Q3 | $4.43M | Buy |
16,109
+693
| +4% | +$190K | 0.03% | 526 |
|
2020
Q2 | $3.5M | Buy |
15,416
+4,022
| +35% | +$914K | 0.02% | 562 |
|
2020
Q1 | $1.74M | Buy |
11,394
+3,477
| +44% | +$529K | 0.01% | 748 |
|
2019
Q4 | $1.19M | Sell |
7,917
-138
| -2% | -$20.7K | 0.01% | 996 |
|
2019
Q3 | $1.14M | Buy |
8,055
+1,656
| +26% | +$235K | 0.01% | 975 |
|
2019
Q2 | $801K | Buy |
6,399
+790
| +14% | +$98.9K | 0.01% | 1158 |
|
2019
Q1 | $618K | Buy |
5,609
+499
| +10% | +$55K | 0.01% | 1273 |
|
2018
Q4 | $501K | Buy |
5,110
+1,588
| +45% | +$156K | ﹤0.01% | 1291 |
|
2018
Q3 | $435K | Sell |
3,522
-1,404
| -29% | -$173K | ﹤0.01% | 1512 |
|
2018
Q2 | $489K | Buy |
4,926
+609
| +14% | +$60.5K | ﹤0.01% | 1405 |
|
2018
Q1 | $381K | Buy |
4,317
+257
| +6% | +$22.7K | ﹤0.01% | 1477 |
|
2017
Q4 | $401K | Buy |
4,060
+884
| +28% | +$87.3K | ﹤0.01% | 1431 |
|
2017
Q3 | $306K | Buy |
3,176
+153
| +5% | +$14.7K | ﹤0.01% | 1490 |
|
2017
Q2 | $286K | Buy |
3,023
+333
| +12% | +$31.5K | ﹤0.01% | 1460 |
|
2017
Q1 | $220K | Sell |
2,690
-200
| -7% | -$16.4K | ﹤0.01% | 1568 |
|
2016
Q4 | $245K | Buy |
+2,890
| New | +$245K | ﹤0.01% | 1447 |
|